Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Archimedes Pharma UK Ltd
250 South Oak Way, Green Park, Reading, RG2 6UG, UK
Telephone: +44 (0)118 931 5050
Fax: +44 (0)118 931 5056
WWW: http://www.archimedespharma.com

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Summary of Product Characteristics last updated on the eMC: 03/01/2012
SPC Sytron

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 03/01/2012 and displayed until Current
Reasons for adding or updating:
  • Change to section 6. 3 - Shelf Life
  • Change to section 10 date of revision of the text
Date of revision of text on the SPC:   01-Mar-2011
Legal Category:   P
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

  • In section 6.3 (shelf life) the shelf life has changed from 60 months to 36 months
  • In Section 10 the date of revision of the text has changed to March 2011
Updated on 11/06/2008 and displayed until 03/01/2012
Reasons for adding or updating:
  • Change of Marketing Authorisation Holder
Date of revision of text on the SPC:   01-Nov-2007
Legal Category:   P
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company
In section 7 the Marketing Authorisation Holder name has changed to Archimedes Pharma Limited, 250 South Oak Way, Green Park, Reading, Berkshire, RG2 6UG, UK
Updated on 06/03/2007 and displayed until 11/06/2008
Reasons for adding or updating:
  • Change to section 6. 3 - Shelf Life
Date of revision of text on the SPC:   06/2006
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company
Update to in-use shelf life.
Updated on 13/02/2006 and displayed until 06/03/2007
Reasons for adding or updating:
  • Change to section 6. 5 - Nature and Contents of Container
Updated on 05/05/2004 and displayed until 13/02/2006
Reasons for adding or updating:
  • Change to section 4.1 - Therapeutic Indications
  • Change to section 9 - Date of Renewal of Authorisation
Updated on 21/08/2001 and displayed until 05/05/2004
Reasons for adding or updating:
  • Change to section 2 - qualitative and quantitative composition
  • Change to section 7 - Marketing Authorisation Holder
Updated on 06/09/1999 and displayed until 21/08/2001
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
  sodium feredetate